The term “Long COVID” first emerged in the social media. Numerous affected individuals have reported in the social media about their various, long-lasting health limitations after SARS-CoV-2 infection. In the Berlin-Brandenburg metropolitan region,…
pharmtrace, a German, Berlin based provider of Independent expertise for nuclear medicine, diagnostics, and drug development clinical trials has established a representative office in Philadelphia. pharmtrace is currently enjoying increasing…
NUVISAN’s integrated drug discovery expertise leveraged in a grant from the Bill & Melinda Gates Foundation
To prevent diseases from occurring in the first place, it is important to identify those individuals who are at particularly high risk as early as possible. Yet current screening methods are often costly and focus only on one disease at a time.…
BRCA1/2-mutated tumor cells often survive treatment, whether it’s chemo- or radiotherapy, because they can repair therapy-induced DNA damage. A team led by Claus Scheidereit of the Max Delbrück Center has now reported in The EMBO Journal how blocking…
If a secretion in the lungs’ alveoli is not cleared regularly, breathing difficulties can develop. In a study published in Science Immunology, a team led by Alexander Mildner and Achim Leutz has now explained the pivotal role of the transcription…
An international research consortium led by the Berlin Institute of Health at Charité (BIH) has secured funding of €7.5 million through the EU’s current Horizon Europe program. The goal of the participating scientific and clinical specialists is to…
Oversubscribed financing round with top-tier life science investors, led by Wellington Partners | Spin-off from Charité – Universitätsmedizin Berlin developing sophisticated AI models to improve understanding, diagnosis and treatment of complex…
- NextPharma to Acquire Takeda’s Manufacturing Site in Asker, Norway
- The Asker Site No Longer Produces Finished Products for Takeda
- Deal Closing is Expected around March 2023
Numerous parameters are measured for patients in the intensive care unit. The AI-based software from x-cardiac GmbH uses this data to calculate whether serious complications will occur. The doctors can then intervene before damage occurs. After…
